Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

a. The dot pattern, b. The subjective visual vertical, and c. Flow chart of the procedure. Participants took part in two sessions following this procedure. In one session the dot pattern remained stationary during exposure (still session), while in the other session the dot pattern rotated (moving session).

More »

Fig 1 Expand

Table 1.

Misery Scale (MISC) after Bos et al. [37].

More »

Table 1 Expand

Fig 2.

a. The sway path length (SPL) in mm (±SEM) and b. Standard deviation in mediolateral direction (SDML) in mm (±SEM) for both groups and all measurement types. VVM patients always exhibited a higher SPL and SDML than healthy controls. VVM patients were significantly more affected by visual deprivation (i.e. eyes closed versus eyes open) than healthy controls. Significant differences at p < .05, p < .01 and p < .0001 are indicated with *, **, and ***, respectively. EC: eyes closed; EO: eyes open; OK: optokinetic.

More »

Fig 2 Expand

Table 2.

Difference contrasts for the interaction between group and measurement type separated for each group for SPL.

More »

Table 2 Expand

Table 3.

Difference contrasts for the interaction between group and measurement type separated for each group for SDML.

More »

Table 3 Expand

Fig 3.

a. The sway path length (SPL) in mm (±SEM) and b. Standard deviation in mediolateral direction (SDML) in mm (±SEM) for both groups and sessions. VVM patients always exhibited a higher SPL and SDML than healthy controls. Both VVM patients and controls had a higher SPL and SDML due to exposure to optokinetic stimulation compared to eyes open. Significant differences at p < .05 are indicated with *.

More »

Fig 3 Expand

Fig 4.

a. Median MISC rate and b. Median SSQ total score (TS) with the symptom cluster scores depicted in the inset. VVM patients always reported more severe symptoms than controls. Both VVM patients and controls reported an increase in symptom severity due to exposure to optokinetic stimulation. Significant differences at p < .05 and p < .01 are indicated with * and **, respectively

More »

Fig 4 Expand

Table 4.

Wilcoxon signed rank tests as a follow-up for significant Friedman tests for the MISC.

More »

Table 4 Expand

Table 5.

Wilcoxon signed rank tests as a follow-up for significant Friedman tests for the SSQ.

More »

Table 5 Expand